Literature DB >> 22418801

[Lessons learned from the "Quirra syndrome" epidemiology? No, thanks].

Pierluigi Cocco1.   

Abstract

Since January 2011, media reports have been reviving claims about a presumed excess of haemolymphopoietic cancer in south-eastern Sardinia, Italy, that started 10 years before.The almost daily sequence of articles created alarm in the local population, and a judicial investigation was initiated. The present commentary discusses possible reasons for the perception of an excess of haemolymphopoietic cancer, which was not confirmed by four independent epidemiological investigations. The update 2003 of the spatial analysis of haemolymphopoietic cancer incidence in southern Sardinia, on the other hand, commissioned by the local health authorities, has suggested an elevated risk of leukaemia among males residing in areas far from those reported at risk.No action followed. It is unclear why the regional authorities do not use the epidemiological investigations commissioned by themselves, whatever the results are either negative or positive for possible environmental health problems.

Entities:  

Mesh:

Year:  2012        PMID: 22418801

Source DB:  PubMed          Journal:  Epidemiol Prev        ISSN: 1120-9763            Impact factor:   1.901


  3 in total

1.  Toxic emissions from a military test site in the territory of Sardinia, Italy.

Authors:  Mauro Cristaldi; Cristiano Foschi; Germana Szpunar; Carlo Brini; Fiorenzo Marinelli; Lucio Triolo
Journal:  Int J Environ Res Public Health       Date:  2013-04-19       Impact factor: 3.390

2.  Haemolymphatic cancer among children in Sardinia, Italy: 1974-2003 incidence.

Authors:  Giorgio Broccia; Jonathan Carter; Cansu Ozsin-Ozler; Federico Meloni; Ilaria Pilia; Giannina Satta; Giulio Murgia; Marcello Campagna; Pierluigi Cocco
Journal:  BMJ Open       Date:  2020-11-03       Impact factor: 2.692

3.  Incidence of non-Hodgkin's lymphoma among adults in Sardinia, Italy.

Authors:  Giorgio Broccia; Jonathan Carter; Cansu Ozsin-Ozler; Federico Meloni; Sara De Matteis; Pierluigi Cocco
Journal:  PLoS One       Date:  2022-02-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.